Jenburkt Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2025 ,inter alia, to consider and approve the audited financial results for the quarter and financial year ended on 31st March, 2025 and recommend dividend, if any.